B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

NR2F1

MOLECULAR TARGET

nuclear receptor subfamily 2 group F member 1

UniProt: P10589NCBI Gene: 70252 compounds

NR2F1 (nuclear receptor subfamily 2 group F member 1) is targeted by 2 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting NR2F1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Progesterone0.691
2Gemfibrozil0.691

About NR2F1 as a Drug Target

NR2F1 (nuclear receptor subfamily 2 group F member 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 2 compounds with documented NR2F1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

NR2F1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.